Acivicin-induced alterations in renal and hepatic glutathione concentrations and in γ-glutamyltransferase activities

Biochemical Pharmacology

Volumn 67, Issue 7, 2004, Pages 1421-1426

  Lantum, Hoffman B M ^a,b   Iyer, Ramaswamy A ^a,c   Anders, M W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b EASTMAN KODAK COMPANY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Lyase; glutamyltransferase; Glutamyltransferase; GT; 2 (fluoromethoxy) 1,1,3, 3,3 pentafluoro 1 propene; Acivicin; Compound A; Glutathione; Glutathione S conjugates; Haloalkenes; Mercapturic acid pathway

Indexed keywords

ACIVICIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; HALOOLEFIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG ACTIVITY; ENZYME ACTIVITY; FEEDING; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE HOMOGENATE;

ANIMALS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; ISOXAZOLES; KIDNEY; LIVER; MALE; RATS; RATS, INBRED F344;

EID: 1542285469     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.10.014     Document Type: Article

References (35)

1. Tate S.S., Meister A. Interaction of γ-glutamyl transpeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione. J. Biol. Chem. 249:1974;7593-7602.
2. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263:1988;17205-17208.
3. Allen L.M., Corrigan M.V., Meinking T. Interaction of AT-125, (αS,5S)-amino-3-chloro-4,5-dihydro-isoxazoleacteic acid, with bovine kidney γ-glutamyl transpeptidase. Chem. Biol Interact. 33:1981;361-365.
4. Anders M.W., Dekant W., Vamvakas S. Glutathione-dependent toxicity. Xenobiotica. 22:1992;1135-1145.
5. Anders M.W., Dekant W. Glutathione-dependent bioactivation of haloalkenes. Annu. Rev. Pharmacol. Toxicol. 38:1998;501-537.
6. Elfarra A.A., Jakobson I., Anders M.W. Mechanism of S-(1,2-dichlorovinyl) glutathione-induced nephrotoxicity. Biochem Pharmacol. 35:1986;283-288.
7. Lash L.H., Anders M.W. Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J. Biol. Chem. 261:1986;13076-13081.
8. Davis M.E. Effects of AT-125 on the nephrotoxicity of hexachloro-1,3-butadiene in rats. Toxicol. Appl. Pharmacol. 95:1988;44-52.
9. de Céaurriz J., Ban M. Role of γ-glutamyltranspeptidase and β-lyase in the nephrotoxicity of hexachloro-1,3-butadiene and methyl mercury in mice. Toxicol. Lett. 50:1990;249-256.
10. Martin J.L., Laster M.J., Kandel L., Kerschmann R.L., Reed G.F., Eger E.I. II Metabolism of Compound A by renal cysteine-S-conjugate β-lyase is not the mechanism of Compound A-induced renal injury in the rat. Anesth Analg. 82:1996;770-774.
11. Martin J.L., Kandel L., Laster M.J., Kerschmann R.L., Eger E.I. II Studies on the mechanism of nephrotoxicity of compound A in rats. J. Anesthesiol. 11:1997;32-37.
12. Kharasch E.D., Thorning D., Garton K., Hankins D.C., Kilty G.C. Role of renal cysteine conjugate β-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology. 86:1997;160-171.
13. Kharasch E.D., Hoffman G.M., Thorning D., Hankins D.C., Kilty C.G. Role of the renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology. 88:1998;1624-1633.
14. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:1968;192-205.
15. Orlowski M., Meister A. γ-Glutamyl-p-nitroanilide: a new convenient substrate for determination and study of L- and D-γ- glutamyltranspeptidase activities. Biochim. Biophys. Acta. 73:1963;679-681.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
17. Reed D.J. Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30:1990;603-631.
18. DeLeve L.D., Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol. Ther. 52:1991;287-305.
19. Beck L.V., Rieck V.E., Duncan B. Diurnal variation in mouse and rat liver sulfhydryl. Proc. Soc. Exp. Biol. Med. 97:1958;229-231.
20. Jaeger R.J., Conolly R.B., Murphy S.D. Diurnal variation of hepatic glutathione concentration and its correlation with 1,1-dichloroethylene inhalation toxicity in rats. Res. Commun. Chem. Pathol. Pharmacol. 6:1973;465-471.
21. Tuñón M.J., González P., López P., Salido G.M., Madrid J.A. Circadian rhythms in glutathione and glutathione-S transferase activity of rat liver. Arch. Int. Physiol. Biochim. Biophys. 100:1992;83-87.
22. Kramer R.A., Foureman G., Greene K.E., Reed D.J. Nephrotoxicity of S-(2-chloroethyl)glutathione in Fischer rat: evidence for γ- glutamyltranspeptidase-independent uptake by the kidney. J. Pharmacol. Exp. Ther. 242:1987;741-748.
23. Lash L.H., Jones D.P. Uptake of the glutathione conjugate S-(1,2-dichlorovinyl)glutathione by renal basal-lateral membrane vesicles and isolated kidney cells. Mol. Pharmacol. 28:1985;278-282.
24. Griffith O.W., Meister A. Translocation of intracellular glutathione to membrane-bound γ-glutamyl transpeptidase as a discrete step in the γ-glutamyl cycle: glutathionuria after inhibition of transpeptidase. Proc. Natl. Acad. Sci. U.S.A. 76:1979;268-272.
25. Reed D.J., Ellis W.W. Influence of γ-glutamyl transpeptidase inactivation on the status of extracellular glutathione and glutathione conjugates. Adv. Exp. Med. Biol. 136A:1982;75-86.
26. Hinchman C.A., Ballatori N. Glutathione-degrading capacities of liver and kidney in different species. Biochem. Pharmacol. 40:1990;1131-1135.
27. Nash J.A., King L.H., Lock E.A., Green T. The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. Toxicol. Appl. Pharmacol. 73:1984;124-137.
28. Ishmael J., Lock E.A. Nephrotoxicity of hexachlorobutadiene and its glutathione-derived conjugates. Toxicol. Pathol. 14:1986;258-262.
29. Gonsowski C.T., Laster M.J., Eger E.I. II, Ferrell L.D., Kerschmann R.L. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology. 80:1994;556-565.
30. Gonsowski C.T., Laster M.J., Eger E.I. II, Ferrell L.D., Kerschmann R.L. Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology. 80:1994;566-573.
31. Jin L., Davis M.R., Kharasch E.D., Doss G.A., Baillie T.A. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane. Chem. Res. Toxicol. 9:1996;555-561.
32. Spracklin D.K., Kharasch E.D. Evidence for metabolism of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether (Compound A), a sevoflurane degradation product, by cysteine conjugate β-lyase. Chem. Res. Toxicol. 9:1996;696-702.
33. Iyer R.A., Anders M.W. Cysteine conjugate β-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (Compound A). Chem. Res. Toxicol. 10:1997;811-8119.
34. Iyer R.A., Baggs R.B., Anders M.W. Nephrotoxicity of the glutathione and cysteine conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1, 1,3,3,3-pentafluoro-1-propene (Compound A) in male, Fischer 344 rats. J. Pharmacol. Exp. Ther. 283:1997;1544-1551.
35. Anders M.W., Lash L., Dekant W., Elfarra A.A., Dohn D.R. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. CRC Crit. Rev. Toxicol. 18:1988;311-341.